As previous reports have shown that BMP signaling directs astroglial differentiation in GSCs36–38, we expected that pSmad2-positive glioma cells would be enriched in stem cell markers, such as Sox2 and nestin, compared to pSmad1-positive glioma cells. This evidence concerns the gene SOX2 and central nervous system cancer.